Bard Associates Inc Lowers stake in II-VI (IIVI)

II-VI (IIVI) : Bard Associates Inc reduced its stake in II-VI by 1.26% during the most recent quarter end. The investment management company now holds a total of 234,344 shares of II-VI which is valued at $4.6 Million after selling 3,000 shares in II-VI , the firm said in a disclosure report filed with the SEC on May 12, 2016.II-VI makes up approximately 2.51% of Bard Associates Inc’s portfolio.

Other Hedge Funds, Including , Zacks Investment Management added IIVI to its portfolio by purchasing 35,370 company shares during the most recent quarter which is valued at $687,947. II-VI makes up approx 0.02% of Zacks Investment Management’s portfolio.Gsa Capital Partners Llp reduced its stake in IIVI by selling 29,828 shares or 44.25% in the most recent quarter. The Hedge Fund company now holds 37,585 shares of IIVI which is valued at $731,028. II-VI makes up approx 0.05% of Gsa Capital Partners Llp’s portfolio.Ngam Advisors boosted its stake in IIVI in the latest quarter, The investment management firm added 2,121 additional shares and now holds a total of 40,305 shares of II-VI which is valued at $830,283. II-VI makes up approx 0.01% of Ngam Advisors’s portfolio. Emerald Advisers Incpa added IIVI to its portfolio by purchasing 134,864 company shares during the most recent quarter which is valued at $2.8 Million. II-VI makes up approx 0.14% of Emerald Advisers Incpa’s portfolio.

II-VI opened for trading at $19.61 and hit $19.84 on the upside on Friday, eventually ending the session at $19.64, with a gain of 0.31% or 0.06 points. The heightened volatility saw the trading volume jump to 2,15,368 shares. Company has a market cap of $1,211,572 M.

On the company’s financial health, II-VI reported $0.35 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on Apr 26, 2016. Analyst had a consensus of $0.28. The company had revenue of $200.90 million for the quarter, compared to analysts expectations of $192.78 million. The company’s revenue was up 10.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.23 EPS.

Many Wall Street Analysts have commented on II-VI. Company shares were Reiterated by The Benchmark Company on Apr 26, 2016 to “Buy”, Firm has raised the Price Target to $ 25 from a previous price target of $23.50 .II-VI was Initiated by Sidoti to “Buy” on Apr 21, 2016. Company shares were Reiterated by Needham on Mar 22, 2016 to “Buy”, Firm has raised the Price Target to $ 23 from a previous price target of $22 .

II-VI Incorporated develops manufactures and markets engineered materials and opto-electronic components and products for precision use in industrial optical communications military semiconductor medical and life science and consumer applications. The Company has three segments: II-VI Laser Solutions II-VI Photonics and II-VI Performance Products. Its II-VI Laser Solutions segment designs manufactures and markets optical and electro-optical components and materials sold under the II-VI Infrared brand and used in carbon dioxide (CO2) lasers. Its II-VI Photonics segment manufactures crystal materials optics microchip lasers and opto-electronic modules for use in optical communication networks and other consumer and commercial applications. Its II-VI Performance Products segment designs manufactures and markets infrared optical components and optical assemblies for military medical and commercial laser imaging applications.

Leave a Reply

II-VI - Is it time to Sell?

Top Brokerage Firms are advising their investors on II-VI. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.